Alumis, Inc. (ALMS)
26.19
-0.15
(-0.57%)
USD |
NASDAQ |
Feb 06, 16:00
26.20
+0.01
(+0.04%)
After-Hours: 20:00
Alumis EPS Diluted (Quarterly) : -1.064 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.390 |
| STAAR Surgical Co. | 0.1758 |
| Insmed, Inc. | -1.747 |
| CorMedix, Inc. | 1.259 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -110.75M |
| Revenue (Quarterly) | 2.066M |
| Total Expenses (Quarterly) | 112.82M |
| Enterprise Value | 2.394B |
| Gross Profit Margin (Quarterly) | 55.66% |
| Profit Margin (Quarterly) | -5.36K% |
| Earnings Yield | -14.72% |
| Normalized Earnings Yield | -14.09 |